QA: Neximmune Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001538210_2024_Neximmune_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001538210, Neximmune Inc

  xvar xval
0 AssetsCurrent 5,400,959
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,352,901
3 remainder_Assets 1,840,089
4 LiabilitiesCurrent 5,084,232
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,000,624
9 ResearchAndDevelopmentExpense 19,282,230
10 remainder_Expenses 690,768
11 remainder_Revenues 0
12 remainder_NetIncome 629,229
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 8,593,949
1 Liabilities 5,084,232
2 Expenses 32,973,622
3 Revenues 0
4 StockholdersEquity 3,509,717
5 NetIncome -32,344,393
6 ComprehensiveNetIncome -32,344,393
7 BaseVar 23,640,516
8 EconomicCapitalRatiobeforeLimitedLiability -3.61
9 EconomicCapitalRatio 0.497

Edgar->Model Mapping

Feature Distribution

Change over Time